XML 18 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:    
Net income $ 12,116 $ 37,852
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 18,766 11,812
Amortization of debt issuance costs 158 148
Provision for doubtful accounts 5,331 4,007
Share-based compensation 3,233 3,147
Deferred income taxes (1,540) (57)
Excess tax benefits from share-based payment arrangements 0 (88)
Change in fair value of contingent consideration 23,794 1,961
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable (72,975) (49,791)
Inventories (37,749) 40,792
Prepaid expenses and other assets (10,081) (20,805)
Other non-current assets (4,775) (1,205)
Accounts payable (11,524) (12,863)
Accrued expenses and other liabilities (5,654) 13,892
Income taxes payable (3,283) 6,929
Net cash (used in) provided by operating activities (84,183) 35,731
Cash flows from investing activities:    
Capital expenditures (3,296) (3,261)
Cash paid for business acquisitions, net of cash acquired (143,768) (83,804)
Net cash (used in) investing activities (147,064) (87,065)
Cash flows from financing activities:    
Borrowings on revolving credit 1,279,193 829,141
Repayments on revolving credit (1,015,672) (764,332)
Debt issuance costs (296) 0
Repayments on capital lease obligation (281) (123)
Contingent consideration payments (54,025) (10,241)
Exercise and issuance of equity awards 2,126 4,217
Taxes paid on settlement of equity awards (1,616) (1,736)
Repurchase of common stock 0 (20,882)
Excess tax benefits from share-based payment arrangements 0 88
Net cash provided by financing activities 209,429 36,132
Effect of exchange rate changes on cash and cash equivalents 1,159 (1,127)
Decrease in cash and cash equivalents (20,659) (16,329)
Cash and cash equivalents at beginning of period 56,094 61,400
Cash and cash equivalents at end of period $ 35,435 $ 45,071